Label: VETIVEX VETERINARY LACTATED RINGERS AND DEXTROSE- dextrose monohydrate, sodium lactate, sodium chloride, potassium chloride, and calcium chloride injection, solution
- NDC Code(s): 17033-494-01
- Packager: Dechra Veterinary Products
- Category: PRESCRIPTION ANIMAL DRUG LABEL
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated September 9, 2020
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
-
Description:
Veterinary Lactated Ringer's and 5% Dextrose Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment and caloric supply in single dose containers for intravenous administration. It contains no antimicrobial agents. Discard unused portion.
Table 1 Veterinary Lactated Ringer's and 5% Dextrose Injection, USP Composition (mg/100mL) Ionic Concentration (mEq/L) kcal/L Size (mL) Dextrose Hydrous, USP
(C6H12O6∙ H2O)Sodium Chloride, USP
(NaCl)Sodium Lactate, USP
(C3H5NaO3)Potassium Chloride, USP
(KCl)Calcium Chloride, USP
(CaCl2∙ 2H2O)Osmolarity (mOsmol/L)
(Calculated)pH Sodium Potassium Calcium Chloride Lactate Caloric Content 1000 5000 600 310 30 20 525 5.0
(4.0 to 6.5)130 4 2.7 109 28 180 -
Clinical Pharmacology:
Veterinary Lactated Ringer's and 5% Dextrose Injection, USP has value as a source of water, electrolytes and calories. It is capable of inducing diuresis depending on the clinical condition of the patient.
Veterinary Lactated Ringer's and 5% Dextrose Injection, USP produces a metabolic alkalinizing effect. Lactate ions are metabolized ultimately to carbon dioxide and water, which requires the consumption of hydrogen cations.
- Indications and Usage:
- Contraindications:
-
Warnings:
Do not administer to horses by intraperitoneal injection.
Veterinary Lactated Ringer's and 5% Dextrose Injection, USP should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states in which there exists edema with sodium retention.
Veterinary Lactated Ringer's and 5% Dextrose Injection, USP should be used with great care, if at all, in patients with hyperkalemia, severe renal failure, and in conditions in which potassium retention is present.
Veterinary Lactated Ringer's and 5% Dextrose Injection, USP should be used with great care in patients with metabolic or respiratory alkalosis. The administration of lactate ions should be done with great care in those conditions in which there is an increased level or an impaired utilization of these ions, such as severe hepatic insufficiency.
Veterinary Lactated Ringer's and 5% Dextrose Injection, USP should not be administered simultaneously with blood through the same administration set because of the likelihood of coagulation.
The intravenous administration of Veterinary Lactated Ringer's and 5% Dextrose Injection, USP can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states, or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of the injections. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injection.
In patients with diminished renal function, administration of Veterinary Lactated Ringer's and 5% Dextrose Injection, USP may result in sodium or potassium retention.
Veterinary Lactated Ringer's and 5% Dextrose Injection, USP is not for use in the treatment of lactic acidosis.
-
Adverse Reactions:
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.
-
Precautions:
Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.
Veterinary Lactated Ringer's and 5% Dextrose Injection, USP must be used with caution. Excess administration may result in metabolic alkalosis.
Caution must be exercised in the administration of Lactated Ringer's and 5% Dextrose Injection, USP to patients receiving corticosteroids or corticotropin.
Veterinary Lactated Ringer's and 5% Dextrose Injection, USP should be used with caution in patients with overt or subclinical diabetes mellitus.
Veterinary Lactated Ringer's and 5% Dextrose Injection, USP is hyperosmolar. Administration of substantially hyperosmolar solutions may cause irritation of the vein, including phlebitis. Hyperosmolar solutions should only be given to animals who are hydrated and receiving maintenance fluid therapy. It is inappropriate to use as a replacement fluid in dehydrated animals where rapid fluid shifts are still occurring from the vascular space into extravascular spaces.
Do not administer unless solution is clear and seal is intact.
-
Dosage and Administration:
As directed by a veterinarian. Dosage is dependent upon the age, weight and clinical condition of the patient as well as laboratory determinations. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.
All solutions for injection contained in plastic containers are intended for administration using sterile equipment and aseptic technique. Additives may be incompatible. Complete information is not available. Those additives known to be incompatible should not be used. Consult with pharmacist, if available. If, in the informed judgment of the veterinarian, it is deemed advisable to introduce additives, use aseptic technique. Mix thoroughly when additives have been introduced.
Do not store solutions containing additives. Discard unused portion.
-
Overdosage:
In an event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures.
See Warnings, Adverse Reactions and Precautions.
- How Supplied:
-
Directions for use of plastic container
To Open
Tear overwrap down side at slit and remove solution bag. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution as sterility may be impaired.
If supplemental medication is desired, follow directions below.
Preparation for Administration
- Suspend container from eyelet support.
- Remove protector from outlet port at bottom of container.
- Attach administration set. Refer to complete directions accompanying set.
To Add Medication
WARNING: Additives may be incompatible.
To add medication before solution administration
- Prepare medication site.
- Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.
- Mix solution and medication thoroughly. For high density medication such as potassium chloride, squeeze ports while ports are upright and mix thoroughly.
To add medication during solution administration
- Close clamp on the administration set to stop the flow to the patient.
- Prepare medication site.
- Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.
- Remove container from IV pole and/or turn to an upright position.
- Evacuate both ports by squeezing them while container is in the upright position.
- Mix solution and medication thoroughly.
- Return container to in-use position and continue administration.
- SPL UNCLASSIFIED SECTION
-
SPL UNCLASSIFIED SECTION
DISTRIBUTED BY:
Dechra Veterinary Products
7015 College Boulevard, Suite 525 Overland Park, KS 66211
Made in El Salvador.
For a copy of the Safety Data Sheet (SDS) or to report adverse reactions call
Dechra Veterinary Products at (866) 933-2472.
© 2017 Dechra Ltd.
Vetivex is a trademark of Dechra Ltd; all rights reserved.Rev. 01/17
- PRINCIPAL DISPLAY PANEL - 1000 mL Container Label
-
INGREDIENTS AND APPEARANCE
VETIVEX VETERINARY LACTATED RINGERS AND DEXTROSE
dextrose monohydrate, sodium lactate, sodium chloride, potassium chloride, and calcium chloride injection, solutionProduct Information Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:17033-494 Route of Administration INTRAVENOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength dextrose monohydrate (UNII: LX22YL083G) (anhydrous dextrose - UNII:5SL0G7R0OK) dextrose monohydrate 50 mg in 1 mL sodium lactate (UNII: TU7HW0W0QT) (lactic acid, unspecified form - UNII:33X04XA5AT, sodium cation - UNII:LYR4M0NH37) sodium lactate 3.1 mg in 1 mL sodium chloride (UNII: 451W47IQ8X) (sodium cation - UNII:LYR4M0NH37, chloride ion - UNII:Q32ZN48698) sodium chloride 6 mg in 1 mL potassium chloride (UNII: 660YQ98I10) (potassium cation - UNII:295O53K152, chloride ion - UNII:Q32ZN48698) potassium chloride 0.3 mg in 1 mL calcium chloride (UNII: M4I0D6VV5M) (calcium cation - UNII:2M83C4R6ZB, chloride ion - UNII:Q32ZN48698) calcium chloride 0.2 mg in 1 mL Inactive Ingredients Ingredient Name Strength Water (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:17033-494-01 1000 mL in 1 CONTAINER Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date UNAPPROVED DRUG OTHER 08/01/2016 Labeler - Dechra Veterinary Products (362142734) Registrant - Dechra Ltd (641097493)
